A phase 2, double-blind, randomized, placebo-controlled, parallel-group, multicenter proof-of-concept study to evaluate the safety and efficacy of Rozerem taken in combination with gabapentin for treatment of subjects with chronic insomnia.

Trial Profile

A phase 2, double-blind, randomized, placebo-controlled, parallel-group, multicenter proof-of-concept study to evaluate the safety and efficacy of Rozerem taken in combination with gabapentin for treatment of subjects with chronic insomnia.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Gabapentin; Ramelteon
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 04 Jun 2010 Additional trial identifier U1111-1114-3348 identified as reported by ClinicalTrials.gov.
    • 18 Sep 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 10 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top